Adding supplemental external beam radiotherapy (EBRT) did not improve outcomes in higher-risk cancer patients who had brachytherapy, according to the long-term results of two trials. Specifically, adding EBRT did not improve biochemical failure (BF) rate or prostate cancer specific mortality (PCSM) in patients who were implanted with brachytherapy palladium 103…
